Yale Cancer Center Seminar: “Improving the Efficiency of Drug Development in Acute Myeloid Leukemia”

Harry P. Erba, of Duke University, is interested in the clinical development of novel therapies for acute myeloid leukemia, myelodysplastic syndromes, myeloproliferative neoplasms (such as chronic myeloid leukemia, polycythemia vera, essential thrombocythemia and myelofibrosis), and acute lymphoblastic leukemia.